In this study, we analyzed the transcriptome profiles of patient-derived cells (PDCs) from NSCLC to identify patient-specific therapeutic targets and found elevated expression of ELF3 in some PDCs. The gene discussed is ELF3; the disease is non-small cell lung carcinoma.